Penumbra

Penumbra, Inc. is a global healthcare company based in Alameda, California. Founded in 2004, it focuses on designing, developing, manufacturing, and marketing innovative medical devices for challenging medical conditions. The company employs over 4,500 people and operates in more than 100 markets worldwide. Penumbra's product portfolio primarily addresses neurovascular and peripheral vascular diseases, with key offerings in stroke treatment, thrombectomy procedures, and embolization. Notable innovations include the Computer-Assisted Vacuum Thrombectomy (CAVT) technology and coil systems for vessel occlusion. The company is dedicated to improving patient outcomes, as demonstrated by recent clinical trials for pulmonary embolism treatment. In 2024, Penumbra reported revenues of $1,194.6 million, reflecting strong sales in the U.S. thrombectomy market. The company is publicly traded under the ticker symbol PEN and serves healthcare providers, hospitals, and clinics globally.